Rapid sterility & mycoplasma testing in cell therapy

Limited production volume, short product shelf life, and the inability to leverage terminal sterilization techniques for living therapies contribute to making safety testing of cell therapies challenging.

Here are ten practical tips for building a more effective contamination control strategy, from method selection and validation planning through to GMP-ready implementation and scale-up.

Read the full infographic below

Please enter your email to access content Read now